GridAI Technologies (GRDX) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
GridAI Technologies (GRDX) has outperformed MIRA Pharmaceuticals (MIRA) over the past year, gaining 6.7% versus a loss of 44.4%. GridAI Technologies is the larger company by market cap ($35.4 million vs $31.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDX | MIRA |
|---|---|---|
| Share price | $4.97 | $0.7455 |
| Market cap | $35.44M | $31.33M |
| 1-day change | +3.54% | +6.05% |
| YTD return | +6.65% | -50.63% |
| 1-year return | +6.65% | -44.37% |
| 5-year return | -99.99% | — |
| EPS (TTM) | $-5.65 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.93 | $2.45 |
| 52-week low | $1.87 | $0.60 |
| Distance from 52-week high | -28.27% | -69.57% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +369.48% |
| Average volume | 104.93K | 585.04K |
| Shares outstanding | 7.13M | 42.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRDX has outperformed MIRA by 51.0 percentage points over the past year.
About GridAI Technologies
GRDX stock →GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.
Health Care · Biotechnology: Pharmaceutical Preparations
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
GRDX vs MIRA FAQ
Which is bigger, GridAI Technologies or MIRA Pharmaceuticals?
GridAI Technologies (GRDX) is larger, with a market capitalization of $35.44M compared with $31.33M for MIRA Pharmaceuticals (MIRA).
Which stock has performed better over the past year, GRDX or MIRA?
GRDX returned +6.65% over the past 12 months, compared with -44.37% for MIRA (price return, excluding dividends). Past performance does not predict future results.
Are GridAI Technologies and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.